HUTCHMED Financials

H7T2 Stock  EUR 2.76  0.06  2.22%   
We strongly advise to harness analysis of HUTCHMED fundamentals to see if markets are currently mispricing the company. We were able to interpolate and analyze data for twenty-four available reported financial drivers for HUTCHMED LS 1, which can be compared to its competitors. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of HUTCHMED to be traded at €3.31 in 90 days.
  
Understanding current and past HUTCHMED Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of HUTCHMED's financial statements are interrelated, with each one affecting the others. For example, an increase in HUTCHMED's assets may result in an increase in income on the income statement.

HUTCHMED Stock Summary

HUTCHMED competes with Eagle Materials, Goodyear Tire, EAGLE MATERIALS, Vulcan Materials, and HF FOODS. HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases worldwide. HUTCHMED Limited was incorporated in 2000 and is headquartered in Central, Hong Kong. HUTCHMED operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1280 people.
InstrumentGermany Stock View All
ExchangeFrankfurt Exchange
ISINKYG4672N1198
Business AddressCheung Kong Center
SectorHealthcare
IndustryBiotechnology
BenchmarkDow Jones Industrial
Websitewww.hutch-med.com
Phone852 2128 1188
CurrencyEUR - Euro
You should never invest in HUTCHMED without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of HUTCHMED Stock, because this is throwing your money away. Analyzing the key information contained in HUTCHMED's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

HUTCHMED Key Financial Ratios

There are many critical financial ratios that HUTCHMED's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that HUTCHMED LS 1 reports annually and quarterly.

HUTCHMED Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining HUTCHMED's current stock value. Our valuation model uses many indicators to compare HUTCHMED value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HUTCHMED competition to find correlations between indicators driving HUTCHMED's intrinsic value. More Info.
HUTCHMED LS 1 is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HUTCHMED's earnings, one of the primary drivers of an investment's value.

HUTCHMED LS 1 Systematic Risk

HUTCHMED's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. HUTCHMED volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on HUTCHMED LS 1 correlated with the market. If Beta is less than 0 HUTCHMED generally moves in the opposite direction as compared to the market. If HUTCHMED Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one HUTCHMED LS 1 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of HUTCHMED is generally in the same direction as the market. If Beta > 1 HUTCHMED moves generally in the same direction as, but more than the movement of the benchmark.

HUTCHMED December 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of HUTCHMED help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of HUTCHMED LS 1. We use our internally-developed statistical techniques to arrive at the intrinsic value of HUTCHMED LS 1 based on widely used predictive technical indicators. In general, we focus on analyzing HUTCHMED Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build HUTCHMED's daily price indicators and compare them against related drivers.

Complementary Tools for HUTCHMED Stock analysis

When running HUTCHMED's price analysis, check to measure HUTCHMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HUTCHMED is operating at the current time. Most of HUTCHMED's value examination focuses on studying past and present price action to predict the probability of HUTCHMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HUTCHMED's price. Additionally, you may evaluate how the addition of HUTCHMED to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios